Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy and safety of the antiplatelet ...
A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, ...
CHICAGO--(BUSINESS WIRE)--Navigant (NYSE:NCI) today announced the expansion of its Financial Services Advisory and Compliance (FSAC) segment with the addition of three senior-level industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback